SCHEMBL8604209

SCHEMBL8604209

COc1cc(OC)c2c(C3=C(O)C(=O)C(c4c[nH]c5cc(OC)cc(OC)c45)=C(O)C3=O)c[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.44
CDK4 P11802 1/20 0.41
CCND1 P24385 1/20 0.41
ABCG2 Q9UNQ0 2/20 0.40
CYP3A4 P08684 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
ME2 P23368 1/20 0.40
ME1 P48163 1/20 0.40
ME3 Q16798 1/20 0.40
PDE3B Q13370 2/20 0.38
PDE3A Q14432 2/20 0.38
KDR P35968 1/20 0.36
ELANE P08246 1/20 0.36
USP2 O75604 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ERN1 O75460 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8604971 0.78 MTNR1A (0.46) EGFRCDK4CCND1CYP3A4ALDH1A1
SCHEMBL8604085 0.72 CNR1 (0.39) EGFRCDK4CCND1ALDH1A1ME2
SCHEMBL7256852 0.72 ALDH1A1 (0.56) EGFRCDK4CCND1ABCG2CYP3A4
SCHEMBL20704965 0.71 ALDH1A1 (0.48) ABCG2ALDH1A1CYP1A2SMN1; SMN2KDM4E
SCHEMBL7262295 0.71 ALDH1A1 (0.57) EGFRABCG2CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL24825685 0.71 ALDH1A1 (0.42) EGFRABCG2ALDH1A1PDE3BPDE3A
SCHEMBL1933389 0.70 EGFR (0.47) EGFRABCG2CYP3A4ALDH1A1KDM4E
SCHEMBL6096141 0.68 HTR2A (0.44) EGFRCDK4CCND1ABCG2ALDH1A1
SCHEMBL27942149 0.68 TUBB1 (0.46) ABCG2ALDH1A1USP2SMN1; SMN2ERN1
SCHEMBL4500573 0.67 ABCG2 (0.49) ABCG2CYP3A4ALDH1A1CYP1A2PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5780496-A Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions SUGEN, INC. (US) 1998-07-14 US claimed
US-5786488-A DEHYDROBROMINATION OF A DIBROMOBENZOQUINONES WITH AT LEAST ONE INDOLES IN A POLAR SOLVENT AND A METAL CARBONATE TO FORM AN ANTITUMOR AGENT SUGEN, INC. (US) 1998-07-28 US disclosed
US-5780496-A Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions SUGEN, INC. (US) 1998-07-14 US disclosed